Effective September 1, 2014, in accordance with the Patient Protection and Affordable Care Act (PPACA) mandate, risk reducing medications such as tamoxifen and raloxifene for women with increased risk of breast cancer will be included as part of the preventive care services benefit under Starmark® self-funded plan designs.
PPACA mandates that non-grandfathered health plans provide coverage without cost-sharing for certain in-network preventive care services for adults and children. Starmark self-funded plan designs include 100% benefits when the services are received from a provider in the health plan’s network. Services may vary by plan/state.
For more information, click here.
Regulatory Updates 